People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sernova Corp. | — | Biotechnology | Pre-Seed | $573K | $2.0M | 2024 |
| Sernova Biotherapeutics Inc. | — | Biotechnology | Pre-Seed | $345K | $695K | 2025 |
Bernd Muehlenweg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bernd Muehlenweg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JAMES PARSONS | 2 | 6 |
| Jonathan Rigby | 2 | 4 |
| John Brooks | 1 | 8 |
| DAVID BURKE | 1 | 3 |
| James T. Parsons | 1 | 2 |
| Jeffrey A. Bacha | 1 | 2 |
| Frank A. Holler | 1 | 2 |
| Marylyn Rigby | 1 | 1 |
| Steven Sangha | 1 | 1 |
| Modestus T. Obochi | 1 | 1 |
| Nicholas Rossettos | 1 | 1 |
| Steven T. Sangha | 1 | 1 |
| Philip Toleikis | 1 | 1 |
| Deborah M. Brown | 1 | 1 |
| Sean Hodgins | 1 | 1 |
| Tanya Lewis | 1 | 1 |
| David Paterson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.